LIRM - Lemanic Institute for Regenerative Medicine is a dedicated non-profit organization focused on advancing drug development and biomarker discovery. Situated in Lausanne, CH, LIRM undertakes impactful research projects and provides support for global education initiatives related to aging and chronic diseases. With a keen interest in stem cells, neurodegeneration, healthy aging, and immunology, LIRM is committed to making significant contributions to the field of biotechnology. LIRM operates at the forefront of regenerative medicine, fostering innovation and collaboration to address some of today's most pressing health challenges.
Driven by a passion for scientific excellence, LIRM - Lemanic Institute for Regenerative Medicine is actively involved in cutting-edge research. The institute’s primary address is in Lausanne, CH, where dedicated researchers work tirelessly to unravel the complexities of aging and chronic diseases. By focusing on key areas such as stem cells and neurodegeneration, LIRM aims to develop novel therapeutic strategies and improve the quality of life for individuals worldwide. The institute’s commitment to global education ensures that the latest advancements in regenerative medicine are shared with researchers and healthcare professionals around the globe.
LIRM’s dedication to biotechnology research makes it a valuable asset to the scientific community. With its focus on innovation, collaboration, and education, LIRM - Lemanic Institute for Regenerative Medicine is poised to make significant strides in the field of regenerative medicine. If you are interested in collaborating, supporting, or learning more about LIRM's projects, please visit their website. We invite the manager of LIRM - Lemanic Institute for Regenerative Medicine to create a customized and exclusive company showcase and product listing on our platform.
Compare LIRM - Lemanic Institute for Regenerative Medicine with 3 companies in Biotechnology-Research
| Comparison Field |
LIRM - Lemanic Institute...Main Company |
Alpha Genomics Priva...View Profile |
ULB HeLSci - Continu...View Profile |
Serendip innovationsView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 2008 | 2023 |
|
Company Size
|
— | 11-50 | 11-50 | 11-50 |
|
City
|
Anderlecht, Brussels Region | Illkirch-Graffenstaden, Grand Est | ||
|
Country
|
Belgium | |||
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Regenerative Medicine
Biomarker Discovery
Stem Cells
Neurodegeneration
Healthy Aging
Immunology
Drug Development
Stem cells
Biotechnology
Aging
|
6 Total
6 Unique
Unique Skills:
Bioinformatics
Genomics
Molecular Biology
Nanotechnology
Next Generation Sequencing
NGS
|
17 Total
17 Unique
Unique Skills:
Biomedical
Career Reorientation
Cell Therapy
Continuing Education
E-learning
employability
+11
|
6 Total
6 Unique
Unique Skills:
Cell-targeting
Infectiology
Modularity & custom design
Nanoparticulate drug delivery system
Oncology
Plant-based Bioproduction
|
Other organizations in the same industry
This company is also known as